Skip to main content
Top
Published in: Journal of Ovarian Research 1/2015

Open Access 01-12-2015 | Research

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma

Authors: Hai Ming Li, Jin Wei Qiang, Gan Lin Xia, Shu Hui Zhao, Feng Hua Ma, Song Qi Cai, Feng Feng, Ai Yan Fu

Published in: Journal of Ovarian Research | Issue 1/2015

Login to get access

Abstract

Purpose

To investigate magnetic resonance imaging (MRI) features for differentiating ovarian endometrioid adenocarcinoma (OEC) from high-grade serous adenocarcinoma (HGSC).

Materials and methods

Twenty-three patients with 25 OECs and 93 patients with 139 HGSCs confirmed by surgery and pathology underwent conventional MRI and diffusion-weighted imaging (DWI). The MRI features of the tumors, including laterality, size, shape, configuration, signal intensity, ADC value of solid component, enhancement, ascites, synchronous primary cancer (SPC) of the ovary and endometrium, and clinical stage, were evaluated and compared between two groups.

Results

The following characteristics were significantly more common for OECs than HGSCs: unilateral (91.3% vs 50.5%, P < 0.001), larger mass (80.0% vs 48.2%, P = 0.005), round or oval shape (64.0% vs 17.3%, P < 0.001), mainly cystic with mural nodules or papillary projections (72.0% vs 18.7%, P < 0.001), cystic component with homogeneous iso- or hyperintensity on T1WI (82.6% vs 4.3%, P < 0.001), moderate enhancement (52.0% vs 26.6%, P = 0.011), no or mild ascites (91.3% vs 57.0%, P = 0.002), and SPC (43.5% vs 4.3%, P < 0.001). The ADC value of the solid component was higher in OECs (0.979 ± 0.197 × 10−3 mm2/s) than in HGSCs (0.820 ± 0.112 × 10−3 mm2/s) (P = 0.002). When a mainly cystic mass with mural nodules or papillary projections was associated with any one of homogeneously iso- or hyperintense cystic component on TIWI, a relatively higher ADC value and SPC, the sensitivity, specificity, accuracy, and positive and negative predictive values for characterizing OEC were 87.0%, 93.5%, 92.2%, 76.9%, and 96.7%, respectively.

Conclusions

Conventional MRI combining DWI is helpful for differentiating OECs from HGSCs.
Literature
1.
go back to reference Feigenberg T, Clarke B, Virtanen C, Plotkin A, Letarte M, Rosen B, et al. Molecular profiling and clinical outcome of hig-grade serous ovarian cancer presenting with low-grade serous ovarian cancer with low-versus high-volume ascites. Biomed Res Int. 2014;2014:367103. doi:10.1155/2014/367103.PubMedCentralPubMed Feigenberg T, Clarke B, Virtanen C, Plotkin A, Letarte M, Rosen B, et al. Molecular profiling and clinical outcome of hig-grade serous ovarian cancer presenting with low-grade serous ovarian cancer with low-versus high-volume ascites. Biomed Res Int. 2014;2014:367103. doi:10.1155/2014/367103.PubMedCentralPubMed
2.
go back to reference Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N. Histologic, molecular and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radio Graphics. 2011;31:625–46. Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N. Histologic, molecular and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radio Graphics. 2011;31:625–46.
3.
4.
go back to reference Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–49.CrossRefPubMed Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–49.CrossRefPubMed
5.
go back to reference Storey DJ, Rush R, Stewart M, Rye T, Al-Nafussi A, Williams AR, et al. Endometrioid epithelial ovarian cancer: 20 years of prospectively collected data from a single center. Cancer. 2008;112:2211–20.CrossRefPubMed Storey DJ, Rush R, Stewart M, Rye T, Al-Nafussi A, Williams AR, et al. Endometrioid epithelial ovarian cancer: 20 years of prospectively collected data from a single center. Cancer. 2008;112:2211–20.CrossRefPubMed
6.
go back to reference Wang S, Qiu L, Lang JH, Shen K, Huang HF, Pan LY, et al. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Am J Obstet Gynecol. 2013;209:241. e1-e9.CrossRefPubMed Wang S, Qiu L, Lang JH, Shen K, Huang HF, Pan LY, et al. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Am J Obstet Gynecol. 2013;209:241. e1-e9.CrossRefPubMed
7.
go back to reference Kitajima K, Kaji Y, Kuwata Y, Imanaka K, Sugihara R, Sugimura K. Magnetic resonance imaging findings of endometrioid adenocarcinoma of the ovary. Radiat Med. 2007;25:346–54.CrossRefPubMed Kitajima K, Kaji Y, Kuwata Y, Imanaka K, Sugihara R, Sugimura K. Magnetic resonance imaging findings of endometrioid adenocarcinoma of the ovary. Radiat Med. 2007;25:346–54.CrossRefPubMed
8.
go back to reference Morgan RJ Jr, Armstrong DK, Alvarez RD, Chen LM, Copeland L, Crispens MA, et al. Ovarian cancer: including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 1. 2014. National Comprehensive Cancer Network; 2014. Morgan RJ Jr, Armstrong DK, Alvarez RD, Chen LM, Copeland L, Crispens MA, et al. Ovarian cancer: including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 1. 2014. National Comprehensive Cancer Network; 2014.
9.
10.
go back to reference McCluggage WG. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology. 2011;43:420–32.CrossRefPubMed McCluggage WG. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology. 2011;43:420–32.CrossRefPubMed
11.
go back to reference Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14:5198–208.CrossRefPubMed Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14:5198–208.CrossRefPubMed
12.
go back to reference Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115:4118–26.CrossRefPubMed Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115:4118–26.CrossRefPubMed
13.
go back to reference Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28:1727–32.CrossRefPubMed Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28:1727–32.CrossRefPubMed
14.
go back to reference Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Nawa A, et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer. 2011;105:1288–94.CrossRefPubMedCentralPubMed Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Nawa A, et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer. 2011;105:1288–94.CrossRefPubMedCentralPubMed
15.
go back to reference Kajiyama H, Mizuno M, Shibata K, Yamamoto E, Kawai M, Nagasaka T, et al. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study. Eur J Obstet Gynecol Reprod Biol. 2014;175:97–102.CrossRefPubMed Kajiyama H, Mizuno M, Shibata K, Yamamoto E, Kawai M, Nagasaka T, et al. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study. Eur J Obstet Gynecol Reprod Biol. 2014;175:97–102.CrossRefPubMed
16.
go back to reference Stewart CJ, Walsh MD, Budgeon CA, Crook ML, Buchanan DB. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis. Pathology. 2013;45:559–66.CrossRefPubMed Stewart CJ, Walsh MD, Budgeon CA, Crook ML, Buchanan DB. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis. Pathology. 2013;45:559–66.CrossRefPubMed
17.
go back to reference Zeppernick F, Meinhold-Heerlein I, Shil IM. Precursors of ovarian cancer in the fallopian tube: Serous tubal intraepithelial carcinoma-an update. J Obstet Gynaecol Res. 2014; doi:10.1111/jog.12550. Zeppernick F, Meinhold-Heerlein I, Shil IM. Precursors of ovarian cancer in the fallopian tube: Serous tubal intraepithelial carcinoma-an update. J Obstet Gynaecol Res. 2014; doi:10.1111/jog.12550.
18.
go back to reference Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012;13:385–94.CrossRefPubMedCentralPubMed Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012;13:385–94.CrossRefPubMedCentralPubMed
19.
go back to reference Mansor S, McCluggage WG. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor:report of a series of cases. Int J Gynecol Pathol. 2014;33:470–6.CrossRefPubMed Mansor S, McCluggage WG. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor:report of a series of cases. Int J Gynecol Pathol. 2014;33:470–6.CrossRefPubMed
20.
go back to reference Gilks CB, Ionescu DN, Kalloger SE, Köbel M, Irving J, Clarke B, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol. 2008;39:1239–51.CrossRefPubMed Gilks CB, Ionescu DN, Kalloger SE, Köbel M, Irving J, Clarke B, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol. 2008;39:1239–51.CrossRefPubMed
21.
go back to reference Tanaka YO, Okada S, Yaqi T, Satoh T, Oki A, Tsunoda H, et al. MRI of endometriotic cysts in assiciotion with ovarian carcinoma. AJR. 2010;194:355–61.CrossRefPubMed Tanaka YO, Okada S, Yaqi T, Satoh T, Oki A, Tsunoda H, et al. MRI of endometriotic cysts in assiciotion with ovarian carcinoma. AJR. 2010;194:355–61.CrossRefPubMed
22.
go back to reference Baert AL, Knauth M, Sartor K. MRI and CT of the Female Pelvis. New York: Springer; 2007. Baert AL, Knauth M, Sartor K. MRI and CT of the Female Pelvis. New York: Springer; 2007.
23.
go back to reference Outwater EK, Huang AB, Dunton CJ, Talerman A, Capuzzi DM. Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging. 1997;7:689–95.CrossRefPubMed Outwater EK, Huang AB, Dunton CJ, Talerman A, Capuzzi DM. Papillary projections in ovarian neoplasms: appearance on MRI. J Magn Reson Imaging. 1997;7:689–95.CrossRefPubMed
24.
go back to reference Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456–62.CrossRefPubMed Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456–62.CrossRefPubMed
25.
go back to reference Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE, et al. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol. 2008;136:78–82.CrossRefPubMed Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE, et al. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol. 2008;136:78–82.CrossRefPubMed
Metadata
Title
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
Authors
Hai Ming Li
Jin Wei Qiang
Gan Lin Xia
Shu Hui Zhao
Feng Hua Ma
Song Qi Cai
Feng Feng
Ai Yan Fu
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2015
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/s13048-015-0154-2

Other articles of this Issue 1/2015

Journal of Ovarian Research 1/2015 Go to the issue